{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:06:03Z","timestamp":1789200363628,"version":"build-2803163510"},"reference-count":28,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Guangdong Natural Science Foundation-General Program","award":["2023A1515011252"],"award-info":[{"award-number":["2023A1515011252"]}]},{"name":"Development Plan \u201cBiosafety Technology\u201d Key Project","award":["2022B1111020003"],"award-info":[{"award-number":["2022B1111020003"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ann Clin Biochem"],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To optimize the retesting process for hepatitis B screening, reduce false positives in samples with weak positive signals, and improve the laboratory management system, ensuring no missed cases and eliminating resource waste.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>131 HBsAg-positive samples with initial signal to cut-off (S\/CO) values ranging from 0.05 to 10 were divided into 5 intervals. After high-speed centrifugation, the samples were retested for HBsAg, and the initial and retest results were compared. By evaluating the repeatability and accuracy of the HBsAg results in different intervals, the \u201cgray zone\u201d of the HBsAg screening test was identified, and a laboratory optimization process plan was established. The new plan was piloted in parallel with the old plan to assess the reliability of the new plan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the interval of initial cut-off (S\/CO) values [0.05\u223c0.2], the difference rate between the initial test group and retest group was the highest (40%), and there was a significant difference in the qualitative results (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; .01). In the interval (1, 2], although there was no significant difference in the qualitative results before and after the retest (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = .47), there were two samples with qualitative differences in the two groups. Under the new plan, the missed detection rate was reduced to 0, and it had excellent clinical application effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>On the premise of ensuring 0 missed detection, fully considering the economic benefits and the rational allocation of resources, the hepatitis B screening \u201cgray zone\u201d is set to [0.05, 2]. For \u201cgray zone\u201d specimens, the retesting process must be implemented.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/00045632261488246","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:07:56Z","timestamp":1788275276000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimization of HBsAg retesting process: An improvement in laboratory management system based on health economics"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3208-9574","authenticated-orcid":false,"given":"Jingrou","family":"Chen","sequence":"first","affiliation":[{"name":"Sun Yat-Sen University"},{"name":"Sun Yat-Sen University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1383-4642","authenticated-orcid":false,"given":"Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen University"},{"name":"Sun Yat-Sen University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1417-5569","authenticated-orcid":false,"given":"Lejian","family":"Dong","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen University"},{"name":"Sun Yat-Sen University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0312-2567","authenticated-orcid":false,"given":"Huimin","family":"Fang","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen University"},{"name":"Sun Yat-Sen University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4818-7532","authenticated-orcid":false,"given":"Xiaoyu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen University"},{"name":"Sun Yat-Sen University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9178-7509","authenticated-orcid":false,"given":"Hongxu","family":"Xu","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen University"},{"name":"Sun Yat-Sen University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.116"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00124-8"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(21)00517-9"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.840825"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13594-y"},{"issue":"1","key":"e_1_3_4_7_2","first-page":"153","article-title":"Comparison of two immunoassays for determining hepatitis B virus serum markers","volume":"50","author":"Xu W","year":"2011","unstructured":"Xu W, Li Y, Wang M, et al. Comparison of two immunoassays for determining hepatitis B virus serum markers. Clin Chem Lab Med 2011; 50(1): 153\u2013157. https:\/\/doi.org\/10.1515\/CCLM.2011.721","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"e_1_3_4_8_2","first-page":"128","article-title":"Application of chemiluminescence immunoassay technology in clinical testing","volume":"37","author":"Ma F","year":"2021","unstructured":"Ma F. Application of chemiluminescence immunoassay technology in clinical testing. Chin Community Doct 2021; 37(2): 128\u2013129. doi:CNKI:SUN: XCYS.0.2021-02-0631.","journal-title":"Chin Community Doct"},{"issue":"01","key":"e_1_3_4_9_2","first-page":"74","article-title":"The grey area of HBsAg enzyme-linked immunosorbent assay (ELISA) in blood screening laboratory","volume":"34","author":"Jin J","year":"2021","unstructured":"Jin J, Xu Y, Jiang R, et al. The grey area of HBsAg enzyme-linked immunosorbent assay (ELISA) in blood screening laboratory. Chinese Journal of Blood Transfusion 2021; 34(01): 74\u201377. https:\/\/doi.org\/10.13303\/j.cjbt.issn.1004-549x.2021.01.0232","journal-title":"Chinese Journal of Blood Transfusion"},{"issue":"07","key":"e_1_3_4_10_2","first-page":"179","article-title":"The relationship between the gray area of HBsAg enzyme-linked immunosorbent assay detection signal and serum immune escape mutant HBsAg","volume":"21","author":"Liang Z","year":"2017","unstructured":"Liang Z. The relationship between the gray area of HBsAg enzyme-linked immunosorbent assay detection signal and serum immune escape mutant HBsAg. Journal of Practical Clinical Medicine 2017; 21(07): 179\u2013183. doi:CNKI:SUN:XYZL.0.2017-07-061.","journal-title":"Journal of Practical Clinical Medicine"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2021.103318"},{"issue":"23","key":"e_1_3_4_12_2","first-page":"13","article-title":"Comparison of chemiluminescence and enzyme-linked immunosorbent assay in the application of hepatitis B virus serological test","volume":"9","author":"Ling H","year":"2023","unstructured":"Ling H. Comparison of chemiluminescence and enzyme-linked immunosorbent assay in the application of hepatitis B virus serological test. Wisdom Health 2023; 9(23): 13\u201321. https:\/\/doi.org\/10.19335\/j.cnki.2096-1219.2023.23.00411","journal-title":"Wisdom Health"},{"key":"e_1_3_4_13_2","first-page":"2","article-title":"Analysis of the application of chemiluminescence immunoassay technology and enzyme-linked immunosorbent assay in hepatitis B virus serological test","volume":"23","author":"Huang Y","year":"2017","unstructured":"Huang Y. Analysis of the application of chemiluminescence immunoassay technology and enzyme-linked immunosorbent assay in hepatitis B virus serological test. Forum of Basic Medicine 2017; 23: 2. https:\/\/doi.org\/10.19435\/j.1672-1721.2017.23.05425","journal-title":"Forum of Basic Medicine"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59030443"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2772-3"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.4081\/cp.2018.1037"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2004.010"},{"issue":"11","key":"e_1_3_4_18_2","first-page":"2","article-title":"Comparative study of ELISA and colloidal gold immunochromatography in the detection of hepatitis B surface antigen","volume":"32","author":"Zhou C","year":"2017","unstructured":"Zhou C, Tu R, Lu F, et al. Comparative study of ELISA and colloidal gold immunochromatography in the detection of hepatitis B surface antigen. Chin J Endemiol 2017; 32(11): 2. doi: CNKI:SUN:DYBF.0.2017-11-02014.","journal-title":"Chin J Endemiol"},{"issue":"4","key":"e_1_3_4_19_2","first-page":"436","article-title":"[Evaluation of different methods in determination of low level HBsAg]","volume":"40","author":"Fei CR","year":"2011","unstructured":"Fei CR, Ye AQ, Zhang J. [Evaluation of different methods in determination of low level HBsAg]. Zhejiang Da Xue Xue Bao Yi Xue Ban 2011; 40(4): 436\u2013439. https:\/\/doi.org\/10.3785\/j.issn.1008-9292.2011.04.016","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.4103\/2141-9248.181835"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29385"},{"issue":"01","key":"e_1_3_4_22_2","first-page":"91","article-title":"Effect of high speed centrifugation on the retesting results of serum markers of four blood-borne infectious diseases","volume":"23","author":"An Z","year":"2016","unstructured":"An Z, Zhang N, Li S, et al. Effect of high speed centrifugation on the retesting results of serum markers of four blood-borne infectious diseases. Immunoassay and Clinical Markers 2016; 23(01): 91\u201394. doi: CNKI:SUN:BJMY.0.2016-01-030.","journal-title":"Immunoassay and Clinical Markers"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"e00390","DOI":"10.1016\/j.plabm.2024.e00390","article-title":"Performance evaluation of the access HBsAg and access HBsAg confirmatory assays on the DxI 9000 access immunoassay analyzer","volume":"39","author":"Visseaux B","year":"2024","unstructured":"Visseaux B, Gautier J, Le Boulaire F, et al. Performance evaluation of the access HBsAg and access HBsAg confirmatory assays on the DxI 9000 access immunoassay analyzer. Pract Lab Med 2024; 39: e00390. https:\/\/doi.org\/10.1016\/j.plabm.2024.e00390","journal-title":"Pract Lab Med"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/labmed\/lmac021"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2339944"},{"issue":"7","key":"e_1_3_4_26_2","first-page":"623","article-title":"[Prevalence of hepatitis B in Chaoyang district, Beijing in 2010]","volume":"46","author":"Zhang XC","year":"2012","unstructured":"Zhang XC, Pang XH, Zhang W, et al. [Prevalence of hepatitis B in Chaoyang district, Beijing in 2010]. Zhonghua Yufang Yixue Zazhi 2012; 46(7): 623\u2013626. Chinese. PMID: 22943918.","journal-title":"Zhonghua Yufang Yixue Zazhi"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1309\/LM4ZM4Q8CQRLZZYG"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.17449"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.21995"}],"container-title":["Annals of Clinical Biochemistry: International Journal of Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00045632261488246","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00045632261488246","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00045632261488246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:18:26Z","timestamp":1789197506000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00045632261488246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":28,"alternative-id":["10.1177\/00045632261488246"],"URL":"https:\/\/doi.org\/10.1177\/00045632261488246","relation":{},"ISSN":["0004-5632","1758-1001"],"issn-type":[{"value":"0004-5632","type":"print"},{"value":"1758-1001","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"00045632261488246"}}